Scandinavian Tobacco Shares Plummet Amid Dividend Cut and Strategic Overhaul

Scandinavian Tobacco's 2025 profit fell 29%, dividend slashed nearly 50%. Shares down 33% as high debt and US market challenges pressure outlook.

Scandinavian Tobacco Group A/S has reported a challenging fiscal year 2025, marked by declining profitability and a cautious outlook that has shaken investor confidence. The company's stock is facing significant selling pressure following the release of its latest financial results, with a sharp reduction in its shareholder payout serving as a major point of concern.

Investor Confidence Erodes with Dividend Reduction

A primary catalyst for the recent equity decline was the board's dividend proposal. The suggested payout of 4.50 DKK per share not only falls substantially short of the previous year's 8.50 DKK but also disappointed market expectations. Compounding the issue, the group's leverage ratio has climbed to three times its EBITDA (earnings before interest, taxes, depreciation, and amortization), exceeding its internal target of 2.5. In response, debt reduction has been prioritized to restore financial stability, with management confirming that no further share buybacks are planned for 2026. The market's reaction was swift and severe: the share price has shed approximately 33% of its value over the past month, trading near 9.27 euros and hovering just above its recent 52-week low.

Financial Performance Under Strain

The conglomerate's net profit contracted by nearly 29% to 669 million Danish kroner for the year. Company leadership attributed this downturn to several factors, including newly imposed tariffs, adverse currency exchange effects, and softer consumer sentiment in the critical U.S. market. Margin compression became particularly evident in the fourth quarter, driven by a sales mix shift toward lower-margin products coupled with increased marketing expenditures in North America.

Further pressure on free cash flow emerged from technical complications during the rollout of a new IT system in Europe, which delayed customer payments. Although these operational issues have reportedly been resolved, their impact was clearly felt in the 2025 financial statements.

Long-Term Strategy Pivots to "Focus2030"

Amid current headwinds, the executive team is banking on a long-term strategic transformation. The "Focus2030" plan aims to aggressively expand the company's nicotine pouch business, a segment that already delivered 17% organic growth. The overarching objective is to elevate the return on capital employed to above 11% by the end of the decade.

For the ongoing 2026 financial year, however, the company anticipates only a stabilization phase. Investments in new product categories and the persistent decline in legacy, high-margin segments are expected to continue influencing near-term results. A clearer picture of the future trajectory will likely emerge following the Annual General Meeting scheduled for April 15, 2026, where shareholders will vote on the dividend proposal and the broader strategic goals.